• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10 Orthopedic Device Firms
    • Buyers' Guide
    • Events
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10 Orthopedic Device Firms
  • Buyers' Guide
  • Events
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    From Nitinol to Nanotubes: A Materials Science Roundtable

    In Good Repair: Trauma Technologies Under Review

    Anxious Undertones: A Review of 2019

    Automated Analysis Advantages for Part Validation

    Tried and True Metalworking
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Orthofix Appoints New Spine Business Leader

    Viant to Halt EtO Sterilization at Michigan Plant by End of Year

    Synaptive Medical's Modus V Expands Into Spine Market

    3D-Printed Graftless Bone Transplants Go to Clinical Trials

    CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    3D-Printed Graftless Bone Transplants Go to Clinical Trials

    CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers

    Micro Spine Implant Could Restore Standing and Walking

    RTI Surgical Appoints New Division Leaders

    From Nitinol to Nanotubes: A Materials Science Roundtable
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Molybdenum-Rhenium Biomaterial: Something ‘MoRe’?

    New Exoskeleton Shoulders Rehab Burden for Stroke Patients

    Repairing Knee Cartilage Defects with the Patient's Own Cells

    Compamed 2019 Preview Report

    Straightening Out a Spinal Device’s De Novo Pathway
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Donatelle

    Orchid Orthopedic Solutions

    NN Life Sciences

    Hammill Medical

    Nelson Laboratories LLC
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10 Orthopedic Device Firms
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    A Healthy Prognosis for Medtech M&A

    A Healthy Prognosis for Medtech M&A
    Related CONTENT
    • AC Mould (Dongguan) Limited
    Mark Bonifacio, Bonifacio Consulting Services05.23.16
    As we get deeper into 2016, many people ask me what I think about the current merger and acquisition (M&A) activity and cycle. Among the most popular questions are: Can it continue? Where are valuations headed? When will it slow down? Who is investing and what areas are attracting investment? While no one likes to make predictions too far into the future, I think it is safe to say that as long as the current backdrop remains unchanged, I see M&A activity continuing throughout this year and early next. Keep in mind though, that the presidential election in November could affect the future direction of medtech investment.

    The Catalysts
    The framework of the Patient Protection and Affordable Care Act (in its current form) will continue to drive to value-based care, where products and procedures are measured by their outcomes and efficacy. Aging populations, a growing global middle class (particularly in developing economies), and a continued increase in chronic diseases all will continue to foster future investment in medical technology. While the United States continues to outspend other countries (it currently accounts for roughly one-third of global healthcare expenditures by most measures), developing countries are growing at double-digit rates. China is approaching $10 billion in healthcare expenditures and has grown more than 15 percent in the past two years; spending there is projected to continue at or above that rate through at least 2020, according to the World Health Organization and other market data. Also, China’s healthcare spending as a percentage of gross domestic product (GDP) is estimated to range between 7 and 8 percent—less than half the total spent on healthcare in the United States (estimated to be 18 percent of GDP). This proves there is plenty of room for growth in emerging markets (with China and the Asia-Pacific region being the largest by far).

    Regardless of your stance on the Affordable Care Act, one point I think everyone will agree on is this: With healthcare spending approaching 20 percent of U.S. GDP, our expenditures cannot continue to grow at this pace, especially when the next nearest developed country is spending only 11 to 12 percent of its GDP with better patient outcomes. This discrepancy will be a big driver in the future of our healthcare. As the U.S. consumer has now increased his awareness along with his out-of-pocket spending, everyone is becoming more conscious of skyrocketing healthcare costs.

    The Backdrop and Playing Field
    Low interest rates, under-deployed capital, and a fragmented market at both the OEM level and the contract manufacturer (CM) level also continue to fuel the M&A fire in the medical device industry. Another key factor is growing competition from strategic buyers (those already in the space and those looking to get in), as well as private equity eager to acquire assets in this fragmented yet attractive space with steady non-cyclical gains.

    The recent spate of OEM consolidation (Medtronic-Covidien, Becton Dickinson and Company–CareFusion, Cardinal Health–Cordis, Stryker Corp.–Sage Products LLC, Zimmer Holdings Inc.–Biomet Inc., and others) will drive the (needed) consolidation of an even more fragmented supplier CM base. OEMs we talk to already have unmanageable supply chains from organically growing over the years, and currently through inheriting the supply chains of their acquisitions. What initially attracted OEMs to CMs—working with “local suppliers” and plant proximity—is changing extremely rapidly. OEMs now prefer to work with full-service CMs that can service them on a global level. Some examples of CM consolidation in recent years is Jabil’s purchase of Nypro, Flextronics’ acquisition of Riwisa AG, TE Connectivity Ltd.’s purchase of both AdvancedCath and Creganna Medical Group, Golden Gate Capital’s partnership with Philips-Medisize, West Pharmaceuticals’ merger with the Tech Group, Accellent’s acquisition of Lake Region Medical, and Hitachi Metals’ purchase of HTP-Meds LLC. Earnings before interest, tax, depreciation, and amortization (EBITDA) multiples continue to impress and remain strong as most of those CM deals were all worth more than 10 times EBITDA.

    Over the last few years, we have also seen other companies trying to enter the space. Techniplex, Nordson Corporation, Molex Inc., Lubrizol Corporation, and others have secured a foothold in the medtech contract manufacturing space through acquisition and appear to be hungry for more deals.

    According to Bloomberg, the top 10 global medical technology companies account for approximately 40 percent of the total market while the top 50 account for about 78 percent of the sector. The five largest finished goods CMs account for roughly 25 percent of the outsourced segment.

    Based on some of our internal research, interviews with OEMs, and market estimates, OEMs outsource between 22 and 27 percent of their manufacturing costs.

    Even as U.S growth in the medical device market continues to cool from past gains, and the inconceivable 18 percent U.S. GDP spending on healthcare, global medtech growth rates will continue to be robust due to demographics and health trends, according to various consultants and research firms. Another contributor is the cost-benefit ratio of medical devices. By many estimates, the approximate expenditures on medical devices in the United States is roughly 5 to 6 percent of the nation’s total domestic healthcare spending. When we think of the enormous benefits many of today’s devices bring to the American population and the improvement to our quality of life, I believe the device sector will continue to be a winner in the value-based market. Those that continue to innovate and look for disruptive changes (not incremental) will certainly lead the pack.

    Medtronic is a perfect example. In 2013, the company collaborated with Apollo Hospitals in India to bring affordable, portable hemodialysis systems to that developing nation to provide end-stage renal disease patients lifesaving therapy from hospital to home.

    What’s Next and What’s New
    Will the market foster more collaborations along the lines of Medtronic’s partnership with Apollo Hospitals? I think the answer is yes, both in the United States and around the world.
    Along with continued M&A, I believe the market will also foster deeper ties between devices and services/procedures as OEMs seek to “own the space” or “own the disease” and the continuum of care for certain conditions and procedures. We may even see some non-traditional acquisitions where device makers want to capture more of a continuum of care from the home to the hospital and back to the home.

    The orthopedic sector has begun to experience such continuum of care ownership with certain conditions, and I believe this trend will begin to stretch across many other disciplines.
    As with many aspects of the healthcare world, in the United States and globally, things do not change rapidly; and adoption curves, especially for disruptive technologies or novel approaches, will take time. We will see pockets of adoption that catch on and become standard as others will not prove to be successful. We are in a highly regulated industry with a great deal of oversight and large portion of government spending. (Note: Despite having a country with private insurance, the American government—thanks to Medicare, Medicaid, the Veterans Administration, and other programs—continues to be the top payor).

    Health system providers, especially not-for-profits (about 40 or so) have started venture funds. While still risky, this risk may be partially offset by the benefits of the technology or products under development. They are also experimenting with new ways of conducting business, usually allowing a lead investor or pure venture capitalist lead the round and preferring instead to act as co-investors.

    Last May, a smartphone app called Heal made its debut. Functioning in much the same way as Uber, the Heal app delivers a doctor to users’ doors in 20 to 60 minutes for a flat fee of $99. Pager and Go2Nurse are also similar app models. Will hospitals soon begin to offer these types of services? Only time will tell.

    Doctor on Demand, introduced in 2013, provides a $40 video consult. Founder Adam Jackson claims 95 percent of people who use the app are diagnosed and treated, with 5 percent referred to specialists.

    “There is a huge access problem to primary care in the United States,” Jackson told The New York Times last May. “The average wait time to see a doctor is 20 days. People really want and need something faster, and now we have the technology on both sides to get it.”

    Telemedicine/telehealth is just one bright spot of innovation that will continue to change how healthcare is provided and delivered. This is not a death knoll to the broader medical device industry, but rather a great opportunity to access more patients and to get them the care (and products) they need.

    Transcatheter aortic valve replacement, minimally invasive surgical procedures, rapid point-of-care diagnostics, and drug delivery all show great promise in the new, value-based era.
    While some pundits debate the merits of adding patients to insurance roles, I think we can all agree that general access to good, affordable healthcare for all of the population will be a good opportunity for providers and device makers alike.

    Disruption is occurring in many sectors and in many forms. And while it rarely occurs overnight, disruption, nevertheless, is taking place in the global healthcare ecosystem. Investment and M&A are almost certain to continue in the near term. The CMs and OEMs that embrace this new landscape and are not afraid to change the way they conduct business (particularly unsuccessful practices of the past) will be handsomely rewarded and lead the pack into the (new) future of global healthcare. 


    Mark Bonifacio is founder and president of Bonifacio Consulting Services LLC, a global consulting and advisory firm to medical device OEMs, contract manufacturers, private equity, and other investors in the medtech manufacturing sector. Bonifacio has a B.S. in plastics engineering from the University of Lowell (now UMASS-Lowell), and more than 25 years of experience in medical device manufacturing across many therapeutic disciplines and market segments. After working for major medical device OEMs, Bonifacio co-founded APEC, a Baldwin Park, Calif.-based contract manufacturer, and sold it to Helix Medical (now Freudenberg Medical) in 2007. He founded Bonifacio Consulting Services in 2008. BCS is headquartered in Boston, Mass., and has offices in California, Florida, and China.
    Related Searches
    • medical device
    • innovation
    • biomet
    • medtech
    Suggested For You
    AC Mould (Dongguan) Limited AC Mould (Dongguan) Limited

    Related Columns

    • Extremities
      Toe Fusion Alternatives Gaining a Firm Market Foothold

      Toe Fusion Alternatives Gaining a Firm Market Foothold

      Dr. Carl Hasselman, co-designer of the Arthrosurface ToeMotion Arthroplasty System, speaks about non-fusion alternatives for MTPJ osteoarthritis.
      Michael Barbella, Managing Editor 12.02.19

    • The Cluster Effect in Orthopedics: Is It Sustainable?

      The Cluster Effect in Orthopedics: Is It Sustainable?

      For a long time, we all assumed Minnesota dominated the medical device industry worldwide, but is this true for the orthopedic surgical tools industry?
      Maria Shepherd, President and Founder, Medi-Vantage 12.02.19

    • ‘If You’re Reading This, You Need to Be at This Meeting’

      ‘If You’re Reading This, You Need to Be at This Meeting’

      The AAOS/FDA/Industry Townhall is taking place March 24, 2020, at the AAOS annual meeting in Orlando.
      Dawn A. Lissy, President & Founder, Empirical 12.02.19


    • Turning the New EU MDR Into a Competitive Advantage

      Turning the New EU MDR Into a Competitive Advantage

      This column examines three new elements of the EU MDR that medical device manufacturers can leverage.
      Dan Goldstein, Associate Director, Quality Assurance, MCRA LLC 12.02.19

    • Design | Large Joint | Spine/Neurology
      Five Reasons for the Small World of Orthopedic Product Development

      Five Reasons for the Small World of Orthopedic Product Development

      Why do product development people tend to stay within the orthopedic and spine industry and not cross over into other medtech sectors?
      Victoria Trafka, BSME, MSME, President and Lead Engineer, Engineering & Quality Solutions Inc. 12.02.19

    • Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      The final quarter of 2019 has begun, which means Congress and the Trump Administration are hard at work finalizing healthcare initiatives before year's end.
      Jeffrey J. Kimbell, David C. Rudloff, and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc. 12.02.19


    • Spine/Neurology
      Pediatric Orthopedics Taken Off the Back Burner

      Pediatric Orthopedics Taken Off the Back Burner

      There are several different types of scoliosis, a condition that causes a sideways spinal curve, that affect children and adolescents.
      Sam Brusco, Associate Editor 09.17.19

    • What Are Orthopedic Surgeon Salary and Employment Statistics?

      What Are Orthopedic Surgeon Salary and Employment Statistics?

      The percent of employed physicians is greater than self-employed physicians.
      Maria Shepherd, President and Founder, Medi-Vantage 09.17.19

    • U.S. May Offer a Safe Harbor from the Impending MDR Storm

      U.S. May Offer a Safe Harbor from the Impending MDR Storm

      There are factors that make for a more inviting environment for the medical device industry in the United States.
      Dawn A. Lissy, President & Founder, Empirical 09.17.19


    • How Identifying Gaps in Clinical Data Can Ease the Transition to New Regulations

      How Identifying Gaps in Clinical Data Can Ease the Transition to New Regulations

      As of 2017, the European medical device market was estimated  at $126 billion, the second largest worldwide, comprising 27 percent of the global market. The European market trails only the United States, which accounts for roughly 43 percent of…
      Mike Goodson, Associate Director, Regulatory Affairs, MCRA LLC 09.17.19

    • Software & Quality
      Benefiting from Paperless Production Records: A Case Study

      Benefiting from Paperless Production Records: A Case Study

      EpiBone discovered how eliminating paper with digital production records can help ensure data integrity, reduce errors, and increase efficiency.
      Terrance Holbrook, Director of Product, MasterControl 09.17.19

    • Connecting the Dots in Medical Device Outsourcing

      Connecting the Dots in Medical Device Outsourcing

      San Francisco is globally renowned for many things: The Golden Gate Bridge (its color, international orange, was actually a primer used to protect the steel during transit), Ghirardelli chocolate, the TransAmerica pyramid building, and the “Pai…
      ODT Staff 08.14.19

    • What Keeps Hospital CEOs Awake at Night and How Can Medtech Help?

      What Keeps Hospital CEOs Awake at Night and How Can Medtech Help?

      With the continued surge of mergers and acquisitions, vertical integrations, and no clear U.S. policy or reform direction for our $3.6 trillion annual healthcare spend,1 the healthcare ecosystem remains in a phase of dramatic disruption. What Is K…
      Maria Shepherd, President and Founder, Medi-Vantage 08.14.19

    • Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry

      Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry

      I’m generally an optimistic person. My outgoing voicemail greeting encourages every caller to “keep smiling!” My wardrobe is about 40 percent “Life is Good” apparel and I keep a daily gratitude journal. Despite this s…
      Dawn A. Lissy, President & Founder, Empirical 08.14.19

    • Successful Strategies for Health Plan Medical Policy Outreach

      Successful Strategies for Health Plan Medical Policy Outreach

      Getting approval from the FDA can be a significant achievement for a company but a bigger challenge awaits for novel technologies: health payor acceptance and coverage. Adopting a novel technology does not occur easily due to complex commercial insur…
      Chelsey Jaworski and Anabel Tapia, MCRA 08.14.19


    Breaking News
    • Orthofix Appoints New Spine Business Leader
    • Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    • Synaptive Medical's Modus V Expands Into Spine Market
    • 3D-Printed Graftless Bone Transplants Go to Clinical Trials
    • CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • From Nitinol to Nanotubes: A Materials Science Roundtable
    • In Good Repair: Trauma Technologies Under Review
    • Anxious Undertones: A Review of 2019
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    International Scientific Society Calls for Omega-3 Blood Testing in Future Research
    Pharmactive Affron Saffron May Help Relieve Depression Symptoms
    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice
    Coatings World

    Latest Breaking News From Coatings World

    Cristo Rey High School Educator Named 2019 Axalta All-Pro Teacher of the Year
    Michelman Makes United Way of Greater Cincinnati’s List of Top 25 Corporate Campaigns
    BCF: Coatings Industry Reports Record Improvement in Waste, Recycling, Accident Rates
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs Roche's Nasal Swab MRSA Test
    Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs
    Eye Test for Parkinson's Gains Breakthrough Designation
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Almac Awarded $1M BMGF Grant
    Vivera Pharma, Parexel Ink Clinical Services Agreement
    MedPharm Triples Capacity at RTP Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    WWP Wins Three NJPEC Awards
    Cat-Themed Beauty Collection to Launch in Japan
    Pantone Names Classic Blue the 2020 Color of the Year
    Happi

    Latest Breaking News From Happi

    Lip Lab Opening in Brooklyn
    Raining Rose Expands Exec Team
    Scott’s Sells Personal Care Production Site
    Ink World

    Latest Breaking News From Ink World

    ePac Flexible Packaging Expands into Asia Pacific Market
    Haney, HP Developing Sustainable Fashion Packaging for Heron Preston
    Addipel Moves to New HQ, Expands Production Facility
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    HP teams with Haney for sustainable packaging
    Tags & Labels Printing adds Heidelberg’s Versafire EP
    Austrian converter installs first Nilpeter press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Thrace to Relocate U.S. Capacity
    FiltXPO Speaker Line-Up Announced
    Nölken Incorporates Sustainable Wipes Packaging
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Appoints New Spine Business Leader
    Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    Synaptive Medical's Modus V Expands Into Spine Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    IDTechEx Show! Announces Graphene Award Winner
    OE-A Continues to Bring Future of Printed Electronics to CES 2020
    Avancis, Smit Thermal, HZB, CNRS, Solliace Team for Higher Efficiencies in CIGS

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.